Breathe Well Live Well
|
Asthma discovery may lead to new therapeutic approach
Insight News Mayo Clinic researchers and collaborators have discovered a key cellular mechanism that contributes to bronchoconstriction and inflammation in asthma. Their studies may lead to a novel, effective asthma therapy for patients. The findings appear in the … |
View full post on asthma – Google News
|
Scientists Identify Receptor for Asthma Associated Virus
Drug Discovery & Development Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have identified a cellular receptor for rhinovirus C, a cold-causing virus that is strongly associated with severe asthma … |
View full post on asthma – Google News
Times of Malta |
Gene discovery could improve asthma therapy
Futurity: Research News Scientists have discovered more than 30 genes that strongly affect an antibody involved in allergies and asthma. Some of the genes could provide targets for drugs to treat those conditions, according to the new study. Allergies affect as much as 30 … Genes involved in Allergies, Asthma identified Genes' 'key role' in asthma Genes involved in allergies, asthma discovered: Scientists |
View full post on asthma – Google News
Drug Discovery & Development |
Study Highlights Drug Targets for Allergies, Asthma
Drug Discovery & Development Illustration of a DNA molecule that is methylated at two sites in the centre. Source: (Max Planck Institute for Informatics) Asthma affects one child in 10 in the UK, and allergies may affect one third of the population. The new findings could lead to … Epigenetic study highlights drug targets for allergies and asthma Asthma cure a step closer after scientists discover 34 genes that make people … Researchers discover promising targets for treating allergies and asthma |
View full post on asthma – Google News
|
Discovery improves understanding of factors that trigger allergic asthma
News-Medical.net However, if these regulatory mechanisms malfunction the cells of the immune system attack innocuous substances which enter the body from the environment, ultimately leading to the development of atopic diseases such as allergic asthma. In western … |
View full post on asthma – Google News
Monthly Prescribing Reference |
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.
Drug Discovery & Development GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in … GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD New Inhalers for Asthma, COPD Launched GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News
Drug Discovery & Development |
New Imaging Method Could Improve Asthma Treatment
Drug Discovery & Development A team of researchers, led by the Universities of Cambridge and Birmingham, have used a laser beam trap to examine how drug particles from asthma inhalers behave as they are projected through the air. Their findings could improve the effectiveness of … |
View full post on asthma – Google News
Drug Discovery & Development |
Newly Developed Vaccines Could Reveal Asthma Clues
Drug Discovery & Development Their potential application to disorders such as asthma has a somewhat different focus. Macrophages that are able to sustain their activation state for prolonged periods might also contribute to chronic lung diseases such as asthma and COPD … Developing Lifesaving Vaccines in a New Way |
View full post on asthma – Google News
|
GSK Submits European, US Filings for Asthma Med
Drug Discovery & Development GlaxoSmithKline announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for approval as a maintenance treatment for patients with severe eosinophilic asthma, identified by a blood eosinophil count of at least 150 cells … GSK Files for Approval of Mepolizumab in US, Europe for Eosinophilic Asthma GSK submits asthma biologic in US, EU GlaxoSmithKline heads to the FDA with its next big respiratory bet |
View full post on asthma – Google News
|
AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and … AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster AstraZeneca share price: Novel drug shows positive results for severe asthma AstraZeneca's benralizumab succeeds in severe asthma |
View full post on asthma – Google News